Tumors with RSLCs morphologically resembling cHL may express prominent CD20, weaker/absent CD30, and absent CD15, whereas tumors resembling PMBL are frequently strongly positive for CD30 and CD15 while negative for CD20 and CD79α [9,34]. This evidence concerns the gene FUT4 and classic Hodgkin lymphoma.